Kenneth R. Deans Jr.
South Carolina
Kenneth R. Deans Jr. is a Contributing Writer for The American Quorum. With 30+ years of leadership across healthcare, technology, and education, he brings an experienced, independent perspective to issues shaping America.
Policy
Nearly 2,000 Flights Canceled in a Single Day: Inside the Structural Collapse Behind America's Summer of Air Travel Chaos
Healthcare
The Hidden Data Layer of Caregiving: Integrating Informal and Formal Dementia Care into Health Systems
Book Reviews
The American Quorum Seeks Volunteer Book Reviewers
Healthcare
Medicare Sets 2.3% Hospital Pay Raise for 2027, Adding $2.9 Billion as Nonprofits Outpace For-Profits
Healthcare
H5N1 Dairy-Cattle Outbreak Reaches 8 States as CDC Tracks First U.S. Human Case Linked to Infected Cows
Tech
Meta Releases Llama 3 in 8B and 70B Models, Trained on More Than 15 Trillion Tokens as Meta AI Expands Across Apps
Healthcare
CDC Warns Measles Resurgence Threatens U.S. Elimination Status as First-Quarter Cases Jump More Than 17-Fold
Tech
Google Unveils Axion Arm CPU and Expands AI Infrastructure as Cloud Providers Race to Build Their Own Silicon
Healthcare
Texas Dairy Worker Tests Positive for H5N1 as U.S. Confirms First Human Bird-Flu Case Linked to Infected Cattle
Tech
Microsoft Separates Teams From Office Worldwide as Antitrust Scrutiny Reshapes Its Enterprise Software Bundles
Healthcare
FDA Approves Winrevair for Pulmonary Arterial Hypertension After Trial Cuts Risk of Death or Clinical Worsening 84%
Tech
AT&T Says Dark-Web Data Set Affects 73 Million Current and Former Customers, Resets Millions of Passcodes
Healthcare
Massachusetts General Transplants Gene-Edited Pig Kidney Into Living Patient, a First for Xenotransplantation
Tech
Justice Department and 16 Attorneys General Sue Apple, Alleging iPhone Monopoly Maintained Through App, Messaging and Device Restrictions
Healthcare
FDA Approves Rezdiffra as First Drug for NASH With Moderate-to-Advanced Fibrosis After Phase 3 Biopsy Gains
Tech
European Parliament Backs AI Act 523-46, Advancing Risk-Based Rules for Generative Models and High-Risk Systems
Healthcare
FDA Expands Wegovy to Cardiovascular Risk Reduction After 17,604-Patient Trial Shows 20% Fewer Major Events
422 stories